B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DAPK3

MOLECULAR TARGET

death associated protein kinase 3

NCBI Gene: 161328 compounds

DAPK3 (death associated protein kinase 3) is targeted by 28 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting DAPK3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1gefitinib5.67290
2erlotinib5.55256
3foretinib4.3476
4tozasertib4.3375
5ruxolitinib4.2368
6pi 1034.1764
7bi 25364.0154
8midostaurin3.8546
9silmitasertib3.7843
10nintedanib3.6136
11pelitinib3.5032
12tae 6843.4330
13fedratinib3.4029
14sp 6001253.2224
15sulfuretin3.1422
16dovitinib3.0921
17jnj 77066213.0921
18lestaurtinib3.0420
19ruboxistaurin2.9418
20r 4062.8316
21kw 24492.6413
22gsk 6906932.6413
23ast 4872.5612
24gsk 4613642.4010
25su 0148132.208
26sp6001251.393
27hydroxyfasudil [Supplementary Concept]1.102
28pictilisib0.691

About DAPK3 as a Drug Target

DAPK3 (death associated protein kinase 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 28 compounds with documented DAPK3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

DAPK3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.